GLP1R and neoplasm: GLP-1 RAs can inhibit cell proliferation by modulating signalling pathways that control the cell cycle and mitosis, suppressing oncogenic pathways like MAPK/ERK and activating tumour-suppressive ones such as AMPK and p53.